Literature DB >> 21108592

GM-CSF: a role in immune and inflammatory reactions in the intestine.

Laia Egea1, Yoshihiro Hirata, Martin F Kagnoff.   

Abstract

Granulocyte macrophage colony-stimulating factor (GM-CSF) is a cytokine that promotes myeloid cell development and maturation, and dendritic cell differentiation and survival in vitro. Growing evidence supports the notion that GM-CSF has a major role in some inflammatory and autoimmune reactions and in the host's response to pulmonary infection, but few studies have addressed its functions and importance in the GI tract. Recent studies demonstrated that administration of GM-CSF can result in clinical improvement in patients with Crohn's disease. Mice deficient in GM-CSF (GM-CSF(-/-) ) developed more severe intestinal and systemic infection after an enteric infection, and more severe colitis in response to enteric exposure to dextran sodium sulfate. Both the severity of infection and colitis were largely prevented by GM-CSF administration. Such studies indicate that GM-CSF has an important role in the regulation of intestinal immune and inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21108592      PMCID: PMC3291482          DOI: 10.1586/egh.10.73

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  71 in total

1.  Sargramostim for active Crohn's disease.

Authors:  Joshua R Korzenik; Brian K Dieckgraefe; John F Valentine; Diana F Hausman; Mark J Gilbert
Journal:  N Engl J Med       Date:  2005-05-26       Impact factor: 91.245

2.  Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch.

Authors:  Mark A Guthridge; Jason A Powell; Emma F Barry; Frank C Stomski; Barbara J McClure; Hayley Ramshaw; Fernando A Felquer; Mara Dottore; Daniel T Thomas; Bik To; C Glenn Begley; Angel F Lopez
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

Review 3.  Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family.

Authors:  R P de Groot; P J Coffer; L Koenderman
Journal:  Cell Signal       Date:  1998-10       Impact factor: 4.315

Review 4.  Functions of granulocyte-macrophage colony-stimulating factor.

Authors:  Andrew J Fleetwood; Andrew D Cook; John A Hamilton
Journal:  Crit Rev Immunol       Date:  2005       Impact factor: 2.214

5.  GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection.

Authors:  A M LeVine; J A Reed; K E Kurak; E Cianciolo; J A Whitsett
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

6.  Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease.

Authors:  K Ina; K Kusugami; T Hosokawa; A Imada; T Shimizu; T Yamaguchi; M Ohsuga; K Kyokane; T Sakai; Y Nishio; Y Yokoyama; T Ando
Journal:  J Gastroenterol Hepatol       Date:  1999-01       Impact factor: 4.029

7.  Receptor clearance obscures the magnitude of granulocyte-macrophage colony-stimulating factor responses in mice to endotoxin or local infections.

Authors:  D Metcalf; N A Nicola; S Mifsud; L Di Rago
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

Review 8.  GM-CSF Biology.

Authors:  John A Hamilton; Gary P Anderson
Journal:  Growth Factors       Date:  2004-12       Impact factor: 2.511

Review 9.  Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors.

Authors:  M A Guthridge; F C Stomski; D Thomas; J M Woodcock; C J Bagley; M C Berndt; A F Lopez
Journal:  Stem Cells       Date:  1998       Impact factor: 6.277

10.  The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells.

Authors:  A Panja; S Goldberg; L Eckmann; P Krishen; L Mayer
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

View more
  38 in total

1.  Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial.

Authors:  F Stephen Hodi; Sandra Lee; David F McDermott; Uma N Rao; Lisa H Butterfield; Ahmad A Tarhini; Philip Leming; Igor Puzanov; Donghoon Shin; John M Kirkwood
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

2.  A Novel Endogenous Damage Signal, CSF-2, Activates Multiple Beneficial Functions of Adipose Tissue-Derived Mesenchymal Stem Cells.

Authors:  Se-Ra Park; Ara Cho; Jae-Wan Kim; Hwa-Yong Lee; In-Sun Hong
Journal:  Mol Ther       Date:  2019-03-19       Impact factor: 11.454

Review 3.  Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma.

Authors:  Darshil J Shah; Roxana S Dronca
Journal:  Mayo Clin Proc       Date:  2014-04       Impact factor: 7.616

4.  ECM1 is an essential factor for the determination of M1 macrophage polarization in IBD in response to LPS stimulation.

Authors:  Yaguang Zhang; Xuezhen Li; Zhongguang Luo; Liyan Ma; Songling Zhu; Zhishuo Wang; Jing Wen; Shipeng Cheng; Wangpeng Gu; Qiaoshi Lian; Xinhao Zhao; Weiguo Fan; Zhiyang Ling; Jing Ye; Songguo Zheng; Dangsheng Li; Hongyan Wang; Jie Liu; Bing Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-24       Impact factor: 11.205

5.  Resident intestinal eosinophils constitutively express antigen presentation markers and include two phenotypically distinct subsets of eosinophils.

Authors:  Jason J Xenakis; Emily D Howard; Kalmia M Smith; Courtney L Olbrich; Yanjun Huang; Dilanjan Anketell; Samuel Maldonado; Evangeline W Cornwell; Lisa A Spencer
Journal:  Immunology       Date:  2018-01-21       Impact factor: 7.397

6.  Single Institution Experience of Ipilimumab 3 mg/kg with Sargramostim (GM-CSF) in Metastatic Melanoma.

Authors:  Jason J Luke; Hilary Donahue; Mizuki Nishino; Anita Giobbie-Hurder; Meredith Davis; Nancy Bailey; Patrick A Ott; F Stephen Hodi
Journal:  Cancer Immunol Res       Date:  2015-05-05       Impact factor: 11.151

7.  GM-CSF produced by nonhematopoietic cells is required for early epithelial cell proliferation and repair of injured colonic mucosa.

Authors:  Laia Egea; Christopher S McAllister; Omar Lakhdari; Ivelina Minev; Steve Shenouda; Martin F Kagnoff
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

Review 8.  Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases.

Authors:  Jason Orlando Dimitri Musci; Jack Stephen Cornish; Jan Däbritz
Journal:  J Gastroenterol       Date:  2016-03-14       Impact factor: 7.527

9.  GM-CSF and GM-CSF receptor have regulatory role in transforming rat mesenteric mesothelial cells into macrophage-like cells.

Authors:  Sándor Katz; Viktória Zsiros; Nikolett Dóczi; Arnold Szabó; Ádám Biczó; Anna L Kiss
Journal:  Inflamm Res       Date:  2016-06-30       Impact factor: 4.575

10.  Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity.

Authors:  I Jurickova; M H Collins; C Chalk; A Seese; R Bezold; K Lake; D von Allmen; J S Frischer; R A Falcone; B C Trapnell; L A Denson
Journal:  Clin Exp Immunol       Date:  2013-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.